Recent AQST Stock Price | AQST Stock Predictions | |
$4.81 | +101.46% |
$9.69 |
Recent AQST Analyst Ratings Breakdown, Making AQST Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 6 | 6 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.14 | 1.14 | 1.14 | 1.14 |
For the AQST stock predictions from the analysts covering Aquestive Therapeutics Inc, we have collected all of the individual AQST stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering AQST (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since AQST stock predictions may vary widely, another useful metric to consider is the median AQST stock prediction, which represents the price at which half of the analysts
made AQST stock predictions that were higher and half made AQST stock predictions that were lower. This makes for a different take on the AQST stock predictions out there, as compared to average or mean.
And that median across all the individual AQST stock predictions was: $9.5 as of 2024-12-03.
The very highest of the AQST stock predictions for one year price target was $15.0, while the very lowest of the AQST stock predictions in the analyst group was
$5.5 (with a standard deviation of $3.104). Get the latest Zacks research report on AQST — FREE
Find out: AQST next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
FARM Stock Predictions
GBT Stock Predictions
RLI Stock Predictions
BKU Stock Predictions
OPCH Stock Predictions
GTES Stock Predictions
TM Stock Predictions
UHS Stock Predictions
GNLN Stock Predictions
|
|
Strong Buy (3.86 out of 4) 78th percentile
(ranked higher than approx. 78% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |